Fumonisin B1 neurotoxicity in young carp (Cyprinus Carpio L.)

Arhiv za Higijenu Rada i Toksikologiju

Volumn 60, Issue 4, 2009, Pages 419-426

  Kovačić, Sanja ^a   Pepeljnjak, Stjepan ^b   Petrinec, Zdravko ^c   Klarić, Maja Šegvić ^b  

^a Zabok General Hospital   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Blood brain barrier; Environment; Mycotoxins; Neurodegenerative diseases

Indexed keywords

FUMONISIN B1; FUMONISIN; MYCOTOXIN; NEUROTOXIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CARP; CELL DEGENERATION; CELL VACUOLE; CONTROLLED STUDY; CORN; EQUINE LEUKOENCEPHALOMALACIA; FUNGUS; FUSARIUM VERTICILLIOIDES; HISTOLOGY; HORSE DISEASE; HYDROPHILICITY; INTOXICATION; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; ANIMAL; BRAIN; DRUG EFFECT; PATHOLOGY; PATHOPHYSIOLOGY;

CYPRINIDAE; CYPRINUS CARPIO; EQUIDAE; FUNGI; FUSARIUM; ZEA MAYS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CARPS; FUMONISINS; MYCOTOXINS; NEUROTOXINS;

EID: 75449118119     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-60-2009-1974     Document Type: Article

References (41)

1. Ince PG, Codd GA. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropath Appl Neurobiol 2005;31:345-353
2. Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol 2009;65:226-229
3. Hirsch-Reinshagen V, Burgess BL, Wellington CL. Why lipids are important for Alzheimer diseasé Mol Cell Biochem 2009;326:121-129
4. Letenneur L, Peres K, Fleury H, Garrigue I, Barberger- Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 2008;3:e3637.
5. Brar S, Henderson D, Schenck J, Zimmerman EA. Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. Arch Neurol 2009;66:371-374
6. Luquin MR, Obeso JA, Herrero MT, Laguna J, Martinez- Lage J. Parkinsonismo inducido por MPTP como modelo experimental de enfermedad de Parkinson: Similitudes y difernencias [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: Similarities and differences, in Spanish]. Neurologia 1991;6:287-294
7. Fuentes JA, Longo VG. An investigation on the central effects of harmine, harmaline and related beta-carbolines. Neuropharmacolog 1971;10:15-23.
8. Barragan LA, Delhaye-Bouchaud N, Laget P. Druginduced activation of the inferior olivary nucleus in young rabbits. Differential effects of harmaline and quipazine. Neuropharmacology 1985;24:645-654
9. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a defi ciency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.
10. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999;22:11-28.
11. Bradbury MWB, editor. The Concept of a Blood-Brain Barrier. 1st ed. Chichester: John Wiley; 1979.
12. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988;54:1806-1811
13. Miller JD. Factors that affect the occurrence of fumonisin. Environ Health Perspect 2001;109(Suppl 2):321-324
14. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 2001;109(Suppl 2):283-289
15. Merrill AH Jr, Liotta DC, Riley RT. Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol 1996;6:218-223
16. Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 1990;57:269-275
17. Colvin BM, Harrison LR. Fumonisin-induced pulmonary edema and hydrothorax in swine. Mycopathologia 1992;117:79-82.
18. Dutton MF. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol Ther 1996;70:137-161
19. Shephard GS, Thiel PG, Sydenham EW, Alberts JF, Gelderblom WC. Fate of a single dose of the 14C-labelled mycotoxin, fumonisin B1, in rats. Toxicon 1992;30:768-770
20. Voss KA, Bacon CW, Norred WP, Chapin RE, Chamberlain WJ, Plattner RD, Meredith FI. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats. Nat Toxins 1996;4:24-33.
21. Brown DW, McCoy CP, Rottinghaus GE. Experimental feeding of Fusarium moniliforme culture material containing fumonisin B1 to channel catfi sh, Ictalurus punctatus. J Vet Diagn Invest 1994;6:123-124
22. Rapoport SI, Matthews K, Thompson HK, Pettigrew KD. Osmotic opening of the blood-brain barrier in the rhesus monkey without measurable brain edema. Brain Res 1977;136:23-29
23. Lillie RD, editor. Histopathologic Technic and Practical Histochemistry. 3rd ed. New York (NY): McGraw-Hill Book Co.; 1965.
24. Scheinker IM. Cerebral swelling: Histopathology, classifi cation and clinical signifi cance of brain edema. J Neurosurg 1947;4:255-275
25. Long DM, Hartmann JF, French LA. The ultrastructure of human cerebral edema. J Neuropathol Exp Neurol 1966;25:373-395
26. Riley RT, Wang E, Schroeder JJ, Smith ER, Plattner RD, Abbas H, Yoo HS, Merrill AH Jr. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat Toxins 1996;4:3-15.
27. Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel PG, van der Lugt JJ. Leukoencephalomalacia in a horse induced by fumonsin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 1988;55:197-203.
28. Harrison LR, Colvin BM, Greene JT, Newman LE, Cole Jr, JR. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 1990;2:217-221
29. Tsunoda M, Dugyala RR, Sharma RP. Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice. Comp Biochem Psysiol C Pharmacol Toxicol Endocrinol 1998;120(3):457-465
30. Kwon OS, Sandberg JA, Slikker W, Jr. Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats. Neurotoxicol Teratol 1997;19(2):151-155
31. Lumlertdacha S, Lovell RT, Shelby RA, Lenz SD, Kemppainen BW. Growth, hematology and histopathology of channel catfi sh, Ictalurus punctatus, fed toxins from F. moniliforme. Aquaculture 1995;130:201-218
32. Marshall WJ, Bangert SK, editors. Clinical Biochemistry: Metabolic and Clinical Aspects. 2nd ed. Edinburgh: Elsevier Health Sciences; 2008.
33. Sharma RP, Bhandari N, Tsunoda M, Riley RT, Voss KA, Meredith FI. Fumonisin toxicity in a transgenic mouse model lacking the mdr1a/1b P-glycoprotein genes. Environ Toxicol Pharmacol 2000;8:173-182
34. Osuchowski MF, He Q, Sharma RP. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier. Food Chem Toxicol 2005;43:1389-1397
35. Zanic-Grubisic T, Santini A, Cepelak I, Barisic K, Juretic D, Pepeljnjak S. Influence of ochratoxin A treatment on the activity of membrane bound enzymes in rat brain regions. Biol Chem Hoppe Seyler 1996;377:121-127
36. Belmadani A, Tramu G, Betbeder AM, Steyn PS, Creppy EE. Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain. Arch Toxicol 1998;72:656-662
37. Wu SN, Chen H, Liu YC, Chiang HT. Block of L-type Ca2+ current by beauvericin, a toxic cyclopeptide, in the NG108-15 neuronal cell line. Chem Res Toxicol 2002;15:854-860
38. Jestoi M. Emerging fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin: a review. Crit Rev Food Sci Nutr 2008;48:21-49.
39. Osuchowski MF, Edwards GL, Sharma RP. Fumonisin B1- induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling. Neurotoxicology 2005;26:212-221
40. Kwon OS, Schmued LC, Slikker W Jr. Fumonisin B1 in developing rats alters brain sphinganine levels and myelination. Neurotoxicology 1997;18:571-579
41. Sunyer J. The neurological effects of air pollution in children. Eur Respir J 2008;32:535-537